-
-
-
-
-
-
-
VistaGen Therapeutics (VTGN) Announces Pricing of $100 Million Underwritten Offering
-
-
-
-
-
-
-
VistaGen Therapeutics to Present at the Jefferies London Healthcare Conference
-
-
-
-
-
-
-
VistaGen Therapeutics Reports Fiscal 2021 Third Quarter Financial Results and Provides Update on Expected Clinical Studies in Calendar 2021
-
-
-
-
-
-
69,742 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

